VanEck Vectors Biotech ETF (BBH)

NASDAQ: BBH · IEX Real-Time Price · USD
+3.09 (2.11%)
Jun 24, 2022 4:00 PM EDT - Market closed
Assets $448.56M
NAV $149.52
Expense Ratio 0.35%
PE Ratio 14.68
Shares Out 3.00M
Dividend (ttm) $0.40
Dividend Yield 0.27%
Ex-Dividend Date Dec 20, 2021
1-Year Return -25.97%
Volume 41,167
Open 147.76
Previous Close 146.43
Day's Range 146.31 - 149.67
52-Week Low 131.12
52-Week High 222.22
Beta 0.86
Holdings 26
Inception Date Dec 20, 2011

About BBH

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Asset Class Equity
Sector Biotech
Region North America
Issuer Van Eck Associates
Stock Exchange NASDAQ
Ticker Symbol BBH
Index Tracked MVIS US Listed Biotech 25 Index

Top 10 Holdings

64.33% of assets
Name Symbol Weight
Amgen AMGN 13.36%
Gilead Sciences GILD 7.86%
Vertex Pharmaceuticals VRTX 7.56%
Regeneron Pharmaceuticals REGN 6.13%
Moderna MRNA 5.78%
Seagen SGEN 5.52%
IQVIA Holdings IQV 4.88%
Biogen BIIB 4.69%
ICON plc ICLR 4.33%
Illumina ILMN 4.22%
View More Holdings


Ex-Dividend Amount Pay Date
Dec 20, 2021 $0.3972 Dec 27, 2021
Dec 21, 2020 $0.6079 Dec 28, 2020
Dec 23, 2019 $0.4724 Dec 30, 2019
Dec 20, 2018 $0.551 Dec 27, 2018
Dec 18, 2017 $0.683 Dec 22, 2017
Dec 19, 2016 $0.327 Dec 23, 2016
Full Dividend History


Basic Could Be Beautiful When Biotech Bounces Back

Biotechnology stocks and exchange traded funds are into a second year of disappointing investors, but that condition won't be permanent. With that in mind, investors evaluating ideas for a biotech resur...

Size Up SBIO as Biotech Catalysts Emerge

Biotechnology stocks and the related exchange traded funds are under pressure as growth stocks stumble this year, but interested investors have some potential positive facts to ponder. First, biotech va...

Other symbols: BBCIBBSBIO

Betting on Biotech Bear Market Expiration Date

Since last year, biotechnology stocks and exchange traded funds have been among the most disappointing equity assets, wilting against the backdrop of the coronavirus pandemic and in advance of broader d...

Other symbols: BBCIBBSBIO

Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

How Are Biotech ETFs Reacting to These Q1 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.


Positioning for Biotech Bounceback

Biotechnology stocks and exchange traded funds have frustrated investors for over a year now, but some analysts and experts believe that this gloomy trend will end soon. Investors willing to take that b...

Other symbols: BBCIBBSBIO

Biotech Stocks, ETFs Starting to Look Healthier

Amid a rebound in growth equities last week, biotech stocks and exchange traded funds got in on the act, and that could be a positive sign for a group that's long been slumbering. For example, the ALPS ...

Other symbols: BBCIBBSBIO

Vaccine Stocks Lift Biotech ETFs as China Enters Lockdowns

Biotechnology sector-related exchange traded funds gained on Monday, with Moderna Inc. (NasdaqGS: MRN) sitting among the top performers in the S&P 500, on renewed COVID-19 concerns as China implements l...

SBIO Is a Good Place to Be for Biotech Innovation

While biotechnology stocks and exchange traded funds continue frustrating market participants in the early innings of 2022, investors should not lose sight of the fact this corner of the healthcare sect...

Other symbols: BBCIBBSBIO

How Are Biotech ETFs Reacting to These Q4 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

Other symbols: IBBXBI

Biotech ETFs Muddled Despite Amgen Strength

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share buy...

Other symbols: IBBIBBQ

Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit

Pfizer is likely to launch Omicron vaccine in March while Moderna is working on a booster that targets the omicron variant of Covid-19.

Other symbols: IHEUSOXLB

Biotech M&A Could Finally Perk Up in 2022

Broadly speaking, mergers and acquisitions in the healthcare sector were steady in 2021, but for many investors, there weren't enough aimed at smaller biotechnology companies. As is often the case, mark...

Other symbols: BBCIBBSBIO

VanEck Announces Yearend Distributions for VanEck Equity ETFs

NEW YORK--(BUSINESS WIRE)--VanEck announced today the following 2021 annual distributions per share for its VanEck® equity exchange-traded funds

Bet on BBH for Biotechnology Bounce Back

Biotechnology equities are lagging the healthcare sector and the broader market this year, but with new variants of the coronavirus expected to continue popping up in 2022, it's impossible to ignore bio...

Smaller Biotech Stocks Ready to Perk Up

If there's an asset class that's looking forward to 2022, it's small- and mid-cap (SMID) biotechnology stocks because that group dealt with a variety of headwinds this year. However, there are more reas...

Other symbols: SBIOBBCIBB

Top ETF Stories of November

The emergence of the Omicron variant of Covid-19 and inflationary pressure were key highlights of the broader market in November.


ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus

The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.

How Are Biotech ETFs Reacting to These Q3 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.


Can Biotech ETFs Gain From Positive Booster Update?

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

Other symbols: BTECFBTIBBXBI

Take a Look at the Top-Performing Biotech ETFs YTD

The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.


Biotech Stocks Have Colds, but They Can Heal

This year hasn't been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to purs...

Other symbols: SBIOBBCIBB

Best ETF Areas for Placing Your Bets in September

Let's take a look at some ETF areas that can be good investment options for September.

5 Top-Ranked ETFs That Outperformed in August

Let's take a look at some top-ranked ETFs that outperformed Wall Street in August.


Biotech ETFs to Benefit From Latest Booster Update

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

Other symbols: BTECFBTIBBXBI